Tech Company Financing Transactions

Threshold Pharmaceuticals Funding Round

Morgenthaler Ventures, CHL Medical Partners and FirstMark Capital invested in a $41 million Series B venture round for Threshold Pharmaceuticals. The round closed on 1/12/2004.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

170 Harbor Way 300
South San Francisco, CA 94080
USA

Phone

(650) 474-8200

Website

www.thresholdpharm.com

Email Address

[email protected]

Overview

Threshold is a biotechnology company focused on the discovery and development of small molecule therapeutics based on Metabolic Targeting, a powerful scientific approach that offers broad potential to treat most solid tumors and certain other diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Harold Selick

        

Chief Medical Officer

Tillman Pearce

        

VP - Bus. Development

Eric Malek

        

VP - Finance

Joel Fernandes

        

VP - Operations

Stewart Kroll

        

Browse more venture capital transactions:

Prev: 1/12/2004: Paratek Microwave venture capital transaction
Next: 1/12/2004: Instantis venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary